Clinical Trial: Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hepatocellular Carcinoma
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications
Brief Summary:
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is given to adult participants to treat advanced solid tumors.ABBV-400 is an investigational drug being developed for the treatment of advanced solid tumors.Study doctors put the participants in groups called cohorts.Each cohort receives ABBV-400 alone (monotherapy) followed by a safety follow-up period.Approximately 220…
Read more